Skip to main content
TOPICS
Videos
Provider
Payer
Pharma
Consumer
Investor
RESOURCES
Events
Jobs
Learning Center
Webinars
White Papers
REGIONS
ANZ
ASIA
EMEA
Global Edition
MORE
About
Advertise
Contact
Privacy Policy
ANZ
ASIA
EMEA
Global Edition
Fenom HOME
Another $15M for Spirosure's respiratory analysis device
By
Dave Muoio
|
05:13 pm |
January 08, 2018
Pleasanton, California-based Spirosure (previously known as Spirometrix) has raised $15 million in Series C-2 financing for its breath analysis device, according to a statement.